Roots of clinical resistance to STI-571 cancer therapy.

Science

Volumn 293, Issue 5538, 2001, Pages 2163-

  Hochhaus, A ^a   Kreil, S ^a   Corbin, A ^a   La Rosee P ^a   Lahaye, T ^a   Berger, U ^a   Cross, N C ^a   Linkesch, W ^a   Druker, B J ^a   Hehlmann, R ^a   Gambacorti Passerini, C ^a   Corneo, G ^a   D'Incalci, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMISTRY; CHRONIC MYELOID LEUKEMIA; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; POINT MUTATION;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, NEOPLASM; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES;

EID: 0035929673     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)